Loading company…
New Haven Pharmaceuticals, based in Guilford, US, develops prescription drugs using established compounds and GRAS ingredients.
New Haven Pharmaceuticals Inc. develops prescription drugs using well-established drugs and GRAS (Generally Recognized as Safe) active pharmaceutical ingredients. It sells to healthcare providers, pharmacies and distributors and targets the United States and Europe. In October 2015 it secured USD 6.3 mn in venture debt from Horizon Technology Finance Corporation, bringing its total raised to USD 11.79 mn.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in